News

Understanding Aktia Bank's Revised Annual Review for 2024

Understanding Aktia Bank's Revised Annual Review for 2024

Correction in Aktia Bank Plc's Annual Review 2024

Aktia Bank Plc has recently acknowledged a correction in its Annual Review for the year 2024. Initially published on March 13, 2025, as part of its broader Annual Report, this review included some erroneous details regarding new fund launches.

Details of the Correction

The necessary amendment pertains specifically to the Asset Management division. The first paragraph under the section titled ‘We continued our determined efforts to develop our award-winning fund selection’ required corrections to accurately reflect the bank’s offerings in 2024.

Corrections in the Asset Management Section

The corrected text clarifies that in 2024, Aktia Bank moved the Aktia Emerging Market Corporate Bond+ fund to the Article 8 classification. Additionally, preparations were made to launch a dark green fund in alignment with Article 9, which integrates sustainability criteria into its investment processes, benefiting from supportive megatrends.

New Fund Launches

Furthermore, the bank streamlined its short-term fixed income offerings by merging the Aktia Stable Yield fund with the Aktia Short-Term Corporate Bond+ fund. This action demonstrates a commitment to enhancing its service. Meanwhile, the focus shifted to launching a European equity fund concentrated on investing in small and medium-sized enterprises throughout Europe.

Partnerships and Innovations

In a strategic alliance with Oaktree Capital Management, the bank introduced the Aktia Velkarahastot II fund, targeting private equity investments in unlisted opportunistic debt. This innovative fund aims to cater to institutional clients and Private Banking customers, highlighting Aktia's dedication to expanding its competitive edge.

Structured Products

Additionally, Aktia issued four structured products during the year, showcasing a commitment to diversifying investment solutions for its clientele. These products represent another step in Aktia's ongoing efforts to provide varied investment options tailored to distinct investor needs.

Company Overview and Financial Standing

Aktia Bank is recognized as a holistic financial institution, combining banking, asset management, and life insurance under one umbrella. With a legacy spanning over 200 years, Aktia is dedicated to fostering financial security and prosperity across generations. Currently, the bank operates across various regions, including Helsinki, Turku, and Tampere, connecting with customers digitally and in-person.

Asset Management Highlights

As of December 31, 2024, Aktia managed assets totaling EUR 14.0 billion. The overall balance sheet reached EUR 11.9 billion, signifying a robust financial foundation. The bank continues to focus on expanding its asset management capabilities, catering to both local and international markets.

Contact for Further Inquiries

For further information, interested parties can reach out to Oscar Taimitarha, Director of Investor Relations, at +358 40 562 2315 or through email.

Frequently Asked Questions

What was corrected in Aktia Bank's Annual Review 2024?

The correction involved details about the launch and classification of specific funds and their investment strategies.

What new funds were introduced by Aktia Bank in 2024?

Aktia launched various funds, including a dark green fund and the Aktia Velkarahastot II, in collaboration with Oaktree Capital Management.

How has Aktia Bank managed its assets recently?

As of the end of December 2024, Aktia has assets under management amounting to EUR 14.0 billion and a balance sheet total of EUR 11.9 billion.

What is the focus of Aktia Bank's investment products?

Aktia Bank emphasizes sustainability in investments and has developed products that align with this vision, like the dark green fund under Article 9.

Who can I contact for more information about Aktia Bank?

Oscar Taimitarha, Director of Investor Relations, is the point of contact for inquiries related to Aktia Bank Plc.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Blokees Unveils 90+ New Wonders at Shanghai Fest

Updated Category News Views 3

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Continue Reading
Monteverde Probes Four Key M&A Deals for Fairness

Updated Category News Views 6

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

Continue Reading
Black Culture Icon: Plastic-Covered Couch Takes Stage

Updated Category News Views 3

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Continue Reading
Class Action Alerts: M&A Under Scrutiny

Updated Category News Views 4

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Continue Reading
ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

Updated Category News Views 5

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Continue Reading
SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Updated Category News Views 3

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Continue Reading
Lawsuit Highlights Inaction in School Bus Tragedy

Updated Category News Views 3

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...

Continue Reading
Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Updated Category News Views 6

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

Continue Reading
Power Knot MEA Wins THE BIZZ 2026 for Excellence

Updated Category News Views 3

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Continue Reading
Monster Energy Dominates Skateboard Podium at SLS Paris

Updated Category News Views 5

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Continue Reading

Top 5 Most Recently Viewed Articles

Strengthening Ties: Xi Jinping and Singaporean PM Wong Unite

Updated Category News Views 364

Strengthening Bilateral Relations for a Brighter Future In a significant meeting that highlights the growing ties between China and Singapore, President Xi Jinping recently welcomed Singaporean Prime Minister Lawrence Wong in Beijing. This engagement underscores the deepening friendship and collaboration between the two nations. During their discussions, President Xi...

Continue Reading
Revolutionizing 5G Processing with Ceva's Innovative Solutions

Updated Category News Views 283

Introduction to a New Era in 5G Technology As the world rapidly embraces the advancement of wireless communication, Ceva, Inc. (NASDAQ: CEVA) is spearheading a groundbreaking collaboration with Arm and SynaXG. This joint effort aims to significantly enhance energy efficiency in 5G New Radio (NR) processing, marking a major milestone for both terrestrial networks and Low...

Continue Reading
Alliance Trust PLC Announces Share Purchase Update

Updated Category News Views 113

Alliance Trust PLC Announces Share Purchase Alliance Trust PLC LEI: 213800SZZD4E2IOZ9W55 TRANSACTION IN OWN SHARES Recently, Alliance Trust PLC, known for its strategic investment approach, made a significant decision by acquiring 50,000 ordinary shares at a price of 1190.0p each. These shares will be held in Treasury, reflecting the company’s proactive strategy in...

Continue Reading
Lilabean Foundation and CBTN Unite for Pediatric Brain Cancer

Updated Category News Views 146

Advancing Pediatric Brain Cancer Research Together The Lilabean Foundation (LBF) is at the forefront of a significant movement to enhance pediatric brain cancer research through its innovative collaboration with the Children's Brain Tumor Network (CBTN). This partnership marks a transformative shift in how childhood brain tumors are treated and understood. Originally a...

Continue Reading
Eli Lilly's Breakthrough Drug EBGLYSS Offers Hope for Eczema

Updated Category News Views 351

A Promising Breakthrough for Eczema Sufferers Eli Lilly and Company (NYSE: LLY) has recently made headlines with the announcement of its innovative drug, EBGLYSS. This medication, functioning as an interleukin-13 (IL-13) inhibitor, has demonstrated substantial improvements in treating patients suffering from moderate-to-severe atopic dermatitis, particularly those who had...

Continue Reading